Sumit Raybardhan

3.6k total citations · 4 hit papers
21 papers, 2.3k citations indexed

About

Sumit Raybardhan is a scholar working on Infectious Diseases, Applied Microbiology and Biotechnology and Epidemiology. According to data from OpenAlex, Sumit Raybardhan has authored 21 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 10 papers in Applied Microbiology and Biotechnology and 6 papers in Epidemiology. Recurrent topics in Sumit Raybardhan's work include Antibiotic Use and Resistance (10 papers), COVID-19 Clinical Research Studies (5 papers) and Nosocomial Infections in ICU (5 papers). Sumit Raybardhan is often cited by papers focused on Antibiotic Use and Resistance (10 papers), COVID-19 Clinical Research Studies (5 papers) and Nosocomial Infections in ICU (5 papers). Sumit Raybardhan collaborates with scholars based in Canada, United States and Australia. Sumit Raybardhan's co-authors include Bradley J. Langford, Valerie Leung, Derek R. MacFadden, Miranda So, Nick Daneman, Duncan Westwood, Jean‐Paul Soucy, Anna Chiu, Lisa Burry and Andrew M. Morris and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy and Clinical Pharmacokinetics.

In The Last Decade

Sumit Raybardhan

21 papers receiving 2.2k citations

Hit Papers

Bacterial co-infection and secondary infection in patient... 2020 2026 2022 2024 2020 2021 2022 2023 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis
    2020 999 citations Bradley J. Langford, Miranda So et al. Clinical Microbiology and Infection profile →
  2. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis
    2021 525 citations Bradley J. Langford, Miranda So et al. Clinical Microbiology and Infection profile →
  3. Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis
    2022 131 citations Bradley J. Langford, Jean‐Paul Soucy et al. Clinical Microbiology and Infection profile →
  4. Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis
    2023 91 citations Bradley J. Langford, Miranda So et al. The Lancet Microbe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sumit Raybardhan Canada 14 1.2k 991 773 382 335 21 2.3k
Valerie Leung Canada 19 1.3k 1.2× 811 0.8× 768 1.0× 386 1.0× 326 1.0× 54 2.4k
Miranda So Canada 15 1.2k 1.0× 812 0.8× 729 0.9× 376 1.0× 350 1.0× 40 2.2k
Mark Gilchrist United Kingdom 23 1.2k 1.1× 750 0.8× 572 0.7× 243 0.6× 492 1.5× 48 2.4k
Makoto Jones United States 27 743 0.6× 774 0.8× 890 1.2× 312 0.8× 316 0.9× 145 2.2k
Bradley J. Langford Canada 25 1.7k 1.5× 947 1.0× 1.1k 1.4× 451 1.2× 406 1.2× 95 3.1k
Melinda M. Neuhauser United States 23 883 0.8× 553 0.6× 896 1.2× 333 0.9× 567 1.7× 73 2.4k
Surbhi Leekha United States 27 582 0.5× 874 0.9× 951 1.2× 298 0.8× 335 1.0× 115 2.6k
Rebekah W. Moehring United States 27 680 0.6× 783 0.8× 675 0.9× 273 0.7× 244 0.7× 123 2.2k
Nina Zhu United Kingdom 15 941 0.8× 729 0.7× 462 0.6× 226 0.6× 374 1.1× 40 2.1k
Arno Müller Belgium 23 1.0k 0.9× 490 0.5× 707 0.9× 213 0.6× 418 1.2× 47 2.1k

Countries citing papers authored by Sumit Raybardhan

Since Specialization
Citations

This map shows the geographic impact of Sumit Raybardhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sumit Raybardhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sumit Raybardhan more than expected).

Fields of papers citing papers by Sumit Raybardhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sumit Raybardhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sumit Raybardhan. The network helps show where Sumit Raybardhan may publish in the future.

Co-authorship network of co-authors of Sumit Raybardhan

This figure shows the co-authorship network connecting the top 25 collaborators of Sumit Raybardhan. A scholar is included among the top collaborators of Sumit Raybardhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sumit Raybardhan. Sumit Raybardhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Langford, Bradley J., Miranda So, Valerie Leung, et al.. (2023). Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis. The Lancet Microbe. 4(3). e179–e191. 91 indexed citations breakdown →
2.
Langford, Bradley J., Jean‐Paul Soucy, Valerie Leung, et al.. (2022). Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis. Clinical Microbiology and Infection. 29(3). 302–309. 131 indexed citations breakdown →
3.
Langford, Bradley J., Miranda So, Valerie Leung, et al.. (2022). Antimicrobial Resistance in Patients with COVID-19: A Systematic Review and Meta-Analysis. SSRN Electronic Journal. 12 indexed citations
4.
Langford, Bradley J., Miranda So, Sumit Raybardhan, et al.. (2021). Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis. Clinical Microbiology and Infection. 27(4). 520–531. 525 indexed citations breakdown →
5.
Moe, Samantha, et al.. (2021). Using a behavioural framework to optimize antibiotic prescribing by family medicine residents. MedEdPublish. 10(1). 113–113. 1 indexed citations
6.
Langford, Bradley J., Miranda So, Valerie Leung, et al.. (2021). Predictors and microbiology of respiratory and bloodstream bacterial infection in patients with COVID-19: living rapid review update and meta-regression. Clinical Microbiology and Infection. 28(4). 491–501. 58 indexed citations
7.
Leung, Elizabeth, Ryan L. Crass, Sarah C J Jorgensen, et al.. (2021). Pharmacokinetic/Pharmacodynamic Considerations of Alternate Dosing Strategies of Tocilizumab in COVID-19. Clinical Pharmacokinetics. 61(2). 155–165. 19 indexed citations
8.
Langford, Bradley J., Miranda So, Sumit Raybardhan, et al.. (2020). Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clinical Microbiology and Infection. 26(12). 1622–1629. 999 indexed citations breakdown →
9.
Raybardhan, Sumit, et al.. (2020). Nurse Prompting for Prescriber-Led Review of Antimicrobial Use in the Critical Care Unit. American Journal of Critical Care. 29(1). 71–76. 15 indexed citations
10.
Chan, Thomas, et al.. (2019). Implementation of a Clinical Decision Support Tool to Improve Antibiotic IV-to-Oral Conversion Rates at a Community Academic Hospital. The Canadian Journal of Hospital Pharmacy. 72(6). 455–461. 6 indexed citations
11.
Langford, Bradley J., Kevin L. Schwartz, Rosemary Zvonar, et al.. (2018). Potential Negative Effects of Antimicrobial Allergy Labelling on Patient Care: A Systematic Review. The Canadian Journal of Hospital Pharmacy. 71(1). 29–35. 32 indexed citations
12.
Bai, Anthony D., Adrienne Showler, Lisa Burry, et al.. (2017). Staphylococcus aureus bacteremia in immunosuppressed patients: a multicenter, retrospective cohort study. European Journal of Clinical Microbiology & Infectious Diseases. 36(7). 1231–1241. 19 indexed citations
13.
Leis, Jerome A., Lesley Palmay, Sumit Raybardhan, et al.. (2017). Point-of-Care β-Lactam Allergy Skin Testing by Antimicrobial Stewardship Programs: A Pragmatic Multicenter Prospective Evaluation. Clinical Infectious Diseases. 65(7). 1059–1065. 45 indexed citations
14.
Raybardhan, Sumit, et al.. (2017). Self-stool banking as a source for fecal microbiota transplantation: A pilot study. Journal of the Association of Medical Microbiology and Infectious Disease Canada. 2(1). 9–14. 3 indexed citations
15.
16.
Bai, Anthony D., Lisa Burry, Adrienne Showler, et al.. (2015). Usefulness of Previous Methicillin‐resistant Staphylococcus aureus Screening Results in Guiding Empirical Therapy for S Aureus Bacteremia. Canadian Journal of Infectious Diseases and Medical Microbiology. 26(4). 201–206. 7 indexed citations
17.
Bai, Anthony D., Adrienne Showler, Lisa Burry, et al.. (2015). Impact of Infectious Disease Consultation on Quality of Care, Mortality, and Length of Stay in Staphylococcus aureus Bacteremia: Results From a Large Multicenter Cohort Study. Clinical Infectious Diseases. 60(10). 1451–1461. 196 indexed citations
18.
Showler, Adrienne, Lisa Burry, Anthony D. Bai, et al.. (2015). Use of Transthoracic Echocardiography in the Management of Low-Risk Staphylococcus aureus Bacteremia. JACC. Cardiovascular imaging. 8(8). 924–931. 24 indexed citations
19.
Bai, Anthony D., Adrienne Showler, Lisa Burry, et al.. (2015). Comparative effectiveness of cefazolin versus cloxacillin as definitive antibiotic therapy for MSSA bacteraemia: results from a large multicentre cohort study. Journal of Antimicrobial Chemotherapy. 70(5). 1539–1546. 65 indexed citations
20.
Raybardhan, Sumit, et al.. (2005). Documenting drug-related problems with personal digital assistants in a multisite health system. American Journal of Health-System Pharmacy. 62(17). 1782–1787. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valerie Leung Breakdown of academic impact, for papers by Miranda So Breakdown of academic impact, for papers by Mark Gilchrist Breakdown of academic impact, for papers by Makoto Jones Breakdown of academic impact, for papers by Bradley J. Langford Breakdown of academic impact, for papers by Melinda M. Neuhauser Breakdown of academic impact, for papers by Surbhi Leekha Breakdown of academic impact, for papers by Rebekah W. Moehring Breakdown of academic impact, for papers by Nina Zhu Breakdown of academic impact, for papers by Arno Müller
Rankless by CCL
2026